PAPER Keshavan A, Pannee J, Karikari TK, Rodriguez JL, Ashton NJ, Nicholas JM, Cash DM, Coath W, Lane CA, Parker TD, Lu K, Buchanan SM, Keuss SE, James SN, Murray-Smith H, Wong A, Barnes A, Dickson JC, Heslegrave A, Portelius E, Richards M, Fox NC, Zetterberg H, Blennow K, Schott JM

Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.

Brain. 2021 Jan 22; PubMed: 33479777

PAPER Melo F, Caballero L, Zamorano E, Ventura N, Navarro C, Doll I, Zamorano P, Cornejo A

The cytotoxic effect of α-synuclein aggregates.

Chemphyschem. 2021 Jan 22; PubMed: 33482036

PAPER Fakhree MA, Konings IB, Kole J, Cambi A, Blum C, M A E Claessens M

The localization of alpha-synuclein in the endocytic pathway.

Neuroscience. 2021 Jan 19; PubMed: 33482328

PAPER Er S

Snca-GFP Knock-In Mice Allows Tracking the Endogenous α-Synuclein in Action.

eNeuro. 2021 Jan-Feb;8(1) Print 2021 Jan-Feb PubMed: 33479114

PAPER Conti E, Sala G, Diamanti S, Casati M, Lunetta C, Gerardi F, Tarlarini C, Mosca L, Riva N, Falzone Y, Filippi M, Appollonio I, Ferrarese C, Tremolizzo L

Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis.

Sci Rep. 2021 Jan 21;11(1):1978. PubMed: 33479441

PAPER Yizibula M, Wusiman Z, Abudouhalike N, Maimaitiming B

Cognitive enhancement and neuroprotective effects of a traditional Chinese herbal compound medicine on Aβ1-42 induced Alzheimer's disease in rats.

Folia Neuropathol. 2020;58(4):365-376. PubMed: 33480241

PAPER Mrdenovic D, Zarzycki P, Majewska M, Pieta IS, Nowakowski R, Kutner W, Lipkowski J, Pieta P

Inhibition of Amyloid β-Induced Lipid Membrane Permeation and Amyloid β Aggregation by K162.

ACS Chem Neurosci. 2021 Jan 22; PubMed: 33478212

PAPER Mahmoudinobar F, Nilsson BL, Dias CL

Effects of Ions and Small Compounds on the Structure of Aβ42 Monomers.

J Phys Chem B. 2021 Jan 22; PubMed: 33481611

PAPER Mahernia S, Hassanzadeh M, Adib M, Peytam F, Haghighijoo Z, Iraji A, Mahdavi M, Edraki N, Amanlou M

The possible effect of microRNA-155 (miR-155) and BACE1 inhibitors in the memory of patients with down syndrome and Alzheimer's disease: Design, synthesis, virtual screening, molecular modeling and biological evaluations.

J Biomol Struct Dyn. 2021 Jan 22;:1-13. PubMed: 33480329

PAPER David B, Schneider P, Schäfer P, Pietruszka J, Gohlke H

Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and in vitro characterisation.

J Enzyme Inhib Med Chem. 2021 Dec;36(1):491-496. PubMed: 33478277

PAPER Cho S, Lee H, Seo J

Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.

Mol Neurobiol. 2021 Jan 21; PubMed: 33479841

PAPER Uddin MS, Al Mamun A, Ashraf GM

Neurotoxic Aβ: Linking Extracellular and Intracellular Aβ in Alzheimer's Disease.

Curr Protein Pept Sci. 2021 Jan 22; PubMed: 33480343

PAPER Balakrishnan J, Kannan S, Govindasamy A

Structured form of DHA prevents neurodegenerative disorders: A better insight into the pathophysiology and the mechanism of DHA transport to the brain.

Nutr Res. 2020 Dec 4;85:119-134. PubMed: 33482601

PAPER Li HD, Funk CC, McFarland K, Dammer EB, Allen M, Carrasquillo MM, Levties Y, Chakrabarty P, Burgess JD, Wang X, Dickson D, Seyfried NT, Duong DM, Lah JJ, Younkin SG, Levey AI, Omenn GS, Ertekin-Taner N, Golde TE, Price ND

Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.

Alzheimers Dement. 2021 Jan 21; PubMed: 33480174

PAPER de Souza MM, Andreolla MC, Ribeiro TC, Gonçalves AE, Medeiros AR, de Souza AS, Ferreira LL, Andricopulo AD, Yunes RA, de Oliveira AS

Structure-activity relationships of sulfonamides derived from carvacrol and their potential for the treatment of Alzheimer's disease.

RSC Med Chem. 2020 Feb 1;11(2):307-316. Epub 2020 Feb 14 PubMed: 33479638